Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

NURSG 331 Exam 2 Study Guide Latest Update 2023 Guaranteed A+, Exams of Nursing

A study guide for the Visual and Auditory Problems module of the NURSG 331 Exam 2. It covers topics such as glaucoma, macular degeneration, and cataracts. The guide includes information on the causes, symptoms, and treatments of these conditions. It also provides nursing care instructions for patients with hearing impairments. intended for nursing students preparing for the exam.

Typology: Exams

2022/2023

Available from 12/02/2023

dillon-cole
dillon-cole 🇺🇸

4.3

(6)

1.9K documents

1 / 31

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
NURSG 331 Exam 2 Study Guide
Latest Update 2023 Guaranteed
A+
Visual and Auditory Problems module (1 part) not as heavily
covered as other 2 mods WebEx Notes
o Eyes and ears not part of Final exam
oGlaucoma, MD, Cataracts - know treatment, clinical manifestations
oHearing- know nursing care of the hearing impaired
Glaucoma *pressure & peripheral vision*
[Lewis Table 20.12, 20.13]
oNormal intraocular pressure: 10 to 21 mm Hg
oCan lead to structural damage.
Optic nerve damage
Loss of peripheral vision
oInflow > outflow IOP increases vision loss
oRisk Factors
Black people over 40
All persons over 60
Family history!!
Strong genetic link
Open angle
Blockage is NOT at the entrance , but inside
Primary Open-Angle Glaucoma (POAG)
oMost common: 60% of all glaucoma
oSlow onset- S/S are often unnoticed because no pain or pressure.
oUsually bilateral, leads to tunnel vision
oCommon in diabetics
oCause
o Blockage of aqueous fluid drainage increasing IOP cupping
of the optic disc
destroys retinal nerve fibers painless vision loss.
oIOP: 22 – 32 mm Hg
Symptoms
oAsymptomatic early
oChange in peripheral vision
oBumping into objects
pg. 1
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16
pf17
pf18
pf19
pf1a
pf1b
pf1c
pf1d
pf1e
pf1f

Partial preview of the text

Download NURSG 331 Exam 2 Study Guide Latest Update 2023 Guaranteed A+ and more Exams Nursing in PDF only on Docsity!

NURSG 331 Exam 2 Study Guide

Latest Update 2023 Guaranteed

A+

Visual and Auditory Problems module (1 part) not as heavily covered as other 2 mods WebEx Notes o Eyes and ears not part of Final exam o Glaucoma, MD, Cataracts - know treatment, clinical manifestations o Hearing- know nursing care of the hearing impaired

  • Glaucoma * pressure & peripheral vision *
  • [Lewis Table 20.12, 20.13] o Normal intraocular pressure: 10 to 21 mm Hg o Can lead to structural damage. ▪ Optic nerve damage ▪ Loss of peripheral vision o Inflow > outflowIOP increases  vision loss o Risk Factors ▪ Black people over 40 ▪ All persons over 60 ▪ Family history!! - Strong genetic link ▪ Open angle - Blockage is NOT at the entrance, but inside - Primary Open-Angle Glaucoma (POAG) o Most common: 60% of all glaucoma o Slow onset- S/S are often unnoticed because no pain or pressure. o Usually bilateral, leads to tunnel vision o Common in diabetics o Cause o Blockage of aqueous fluid drainage  increasing IOP  cupping of the optic disc  destroys retinal nerve fibers  painless vision loss. o IOP: 22 – 32 mm Hg - Symptoms o Asymptomatic early o Change in peripheral vision o Bumping into objects

o Many assume normal aging changes o Dx : elevated IOP (22-32mm/Hg), visual field loss, cupping of optic nerve

- Treatment o Medications ▪ Miotic Drops - pupil constriction and reduce formation of aqueous humor - Sx: burning, blurred vision ▪ Beta Blockers - Decreases production of aqueous humor - Sx : burning, tearing, slowed HR, fatigue ▪ Topical Steroids

▪ Use of eye drops ▪ Prevent increase of IOP ▪ Avoid bending

  • Raise foot to tie shoe
  • Push heavy objects (don’t pick up/lift) ▪ Avoid steroids
  • Steroids increase IOP ▪ ID band ▪ Avoid sneezing, coughing

▪ Contact MD if sudden painless loss of vision ▪ Take drops

  • Burning & blurring vision are short lived - Macular degeneration central vision loss o Most common cause of central vision loss in people over 60 in the US o Types Dry vs. Wet ▪ Dry (nonexudative)
  • More common: 90% of cases
  • Slowly progressive macular atrophy
  • Causes painless vision loss and accumulation of yellowish (drusen) deposits ▪ Wet (exudative)
  • More severe that leads to blindness with a rapid onset
  • From abnormal blood vessels near macula o Leak and cause scar tissue
  • Had dry first o Causes ▪ Aging, genetics, UV exposure, smoking ▪ Hyperopia ▪ Light colored eyes ▪ Lack of nutrient intake
  • Eating dark leafy green vegetables (kale and spinach) may reduce risk o Need more Vit. C, E, lutein, zeaxanthin and zinc o Increased incidence : White people o S/S ▪ Blurred vision, dark (blind) spots, and visual distortions o Care ▪ No smoking ▪ Vitamin/mineral supplements ▪ Intraocular injections of endothelial growth factor inhibitors
  • For Wet MD ▪ Photodynamic therapy: uses an IV med and a cold laser.
  • It takes days for the dye to pass which is activated by light.
  • The patient MUST be covered and stay out of light for at least 5 days or they could suffer burns!
  • Cataracts opacity within the lens
  • [Lewis Table 20.8, 20.9] o Loss of transparency of the lens o #1 cause of blindness o Caused by chemical changes ( normal aging ) within the protein material of the lens  clouding, yellow or brown discoloration o Contributing factors ▪ Sunlight ▪ poor nutrition ▪ Smoking

▪ Diabetes mellitus o Common ▪ 25% of population, over 55. Over 22 million globally o Myths ▪ Not caused by over-using eyes, Not contagious or R/T cancer, Not a film or coating, Not spread from eye-to-eye o Symptoms ▪ No known means to reverse clouding Usually bilateral ▪ Like looking through foggy window ▪ Painless , progressive loss of vision ▪ Abnormal color vision ▪ Glare, esp at night

  • Bad for night driving ▪ Amount of vision loss R/T location & degree of clouding o Treatment ▪ Prescription glasses
  • Central vision is corrected, peripheral vision is distorted
  • 30% magnification o Adjustment needed for ADL’s (judging distances) ▪ Surgery
  • Must assess vision of un-operative eye
  • Outpatient, one eye at a time
  • Removal of the clouded lens and replaced with an intraocular lens implant (IOL). o Allows the eye to focus again clearly
  • Proper eyewear can further enhance vision ▪ Sometimes informing and reassuring the patient about the disease process makes the patient comfortable about choosing nonsurgical measures, at least temporarily. o Post-op Care & Complications ▪ Care
  • After sedatives wear off, patients are usually go home.
  • Permanent glasses prescribed after 3 months
  • Usually discharged with eye drops
  • Call MD if increased pain in operative eye o PT SHOULD NOT HAVE PAIN - Avoid increase of IOP o Activities: bending or stooping, coughing, or lifting.
  • Clean inner  outer
  • Shaded lenses, eye shield o Nighttime eye shielding
  • Showers, hair washed with head held backward
  • Sex in 6-8 weeks - Postoperative medications o Antibiotic drops (prevent infection) o Corticosteroid drops (decrease post-op inflammation)
  • During each postoperative examination, the ophthalmologist will measure the patient’s visual acuity, check anterior chamber depth, assess corneal clarity, and measure IOP. ▪ Complications

WebEx Notes o Knowing type 1 and 2, hypo and hyperglycemia – what does it look like, what do we do for these, what teaching can we do (lot of teaching with DM) o Diabetes insipidus- has NOTHING to do with blood sugar- has more to do with fluids o Know normal blood sugar ranges, A1C, some electrolytes that play into this

Table 48.1: Differences between Type 1 & 2 pg. 1109 Table 48.2: Interprofessional Care

  • Diagnostic Assessment o History and physical exam o Blood tests: fasting BG, postprandial BG, A1C, fructosamine, lipid profile, BUN and serum creatnine, elecrrolytes, islet of cell autoantibodies o Urine analysis o BP o ECG (if indicated) o Funduscopic exam (dilated eye exam) o Dental exam o Neurological exam o Ankle-brachial index (ABI) o Food (podiatric) exam o Monitoring of weight
  • Management o Pt and caregiver teaching & follow-up programs o Nutrition therapy o Exercise therapy o Self-monitoring BG
  • Drug Therapy o Insulin o OA Type 1 diabetes
  • Cause o Autoimmune disorder in which the body develops antibodies against insulin and/or the pancreatic β cells that produce insulin. This eventually results in not enough insulin for a person to survive. o Autoantibodies to the islet cells cause a reduction of 80% to 90% of normal function before hyperglycemia and other manifestations occur. ▪ May take months to years before S/S occur
  • Clinical Manifestations o Onset is rapid, 1 st manifestations are usually acute o Polyuria, polydipsia & polyphagia (3 P’s) ▪ Osmotic fx of excess glucose  polydipsia & polyuria ▪ Cellular malnourishment from insulin deficiency prevents cells from using glucose for energy 
  • 30 days for one insulin o Typically injected subcutaneously ▪ Intramuscularly can cause rapid or unpredictable absorption which can cause hypoglycemia o Insulin pump ▪ users check their blood glucose level at least four times per day. Monitoring eight times or more per day is common. ▪ Advantage: keeps blood glucose levels in a tighter range because insulin delivery becomes very similar to the normal physiologic pattern. o Complications ▪ Hypoglycemia, allergic reactions, lipodystrophy, and the Somogyi effect. ▪ Local inflammatory reactions: itching, erythema, and burning sensation around the injection site.
  • Local reactions may be self-limiting within 1 to 3 months or may improve with a low dose of antihistamine. ▪ A true insulin allergy is rare. It is manifested by a systemic response with urticaria and possibly anaphylactic shock.
  • Zinc or protamine, used as preservatives in the insulin, and the latex or rubber stoppers on the vials have been implicated in allergic reactions. ▪ Lipodystrophy (atrophy or hypertrophy of subcutaneous tissue) may occur if the same injection sites are used frequently.
  • The use of hypertrophied sites may result in erratic insulin absorption.
  • Diabetic Ketoacidosis (DKA) o Causes: decreased or missed insulin dose, illness or infection, untreated diabetes

o S&S: acetone breath, low BP, hyper or hypokalemia, metabolic acidosis,

anorexia, nausea, vomiting, abdominal pain, increased RR, blurred vision, polyuria, weakness, HA, polydipsia, hypotension, tachycardia, sunken eyes, slow turgor. o Metabolic Acidosis ▪ hyperkalemia  hypokalemia (watch very closely) o Treatment ▪ fluid resuscitation ▪ Low dose IV insulin in .9 NS

  • lower slowly to prevent rebound cerebral edema, add D5 to solution once BS at 250 (prevents severe hypoglycemic drop) ▪ Follow sick day rules to prevent DKA r/t illness
  • Take insulin/oral agents as usual
  • Acuchecks q3hrs
  • Report BSL >
  • IDDM pts may need regular insulin q3hrs
  • Eat jello, cream soup, custard, graham crackers 6-8 times/day
  • Prevent dehydration by drinking ½ cup OJ, soda, broth, or 1 cup

Gatorade q30min

  • Report extreme vomiting, diarrhea
  • Type I may need hospitalization if unable to retain fluids Type 2 diabetes
  • Clinical Manifestations o May have 3 P’s too o More common ▪ Fatigue ▪ Recurrent infections

Diagnostics for DM o A1C: 6.5% or higher o Fasting plasma glucose : 126 mg/dL or higher o 2-hr plasma glucose level: 200 mg/dL or higher

▪ Oral glucose tolerance testing is no longer recommended for routine clinical use. Tests to distinguish Type 1 vs 2 o Presence of endogenous insulin = Type 2 ▪ Endogenous insulin is absent in Type 1 o Islet cell antibody testing ▪ Positive = Type 1 Teaching for Diabetic Pts

  • Nutritional therapy
  • Drug therapy
  • Exercise o Lowers BSL by increasing uptake of glucose by muscles o Improves circulation & muscle tone, facilitates wt loss o Pts with uroketones should NOT exercise ▪ If BSL > 250, no exercise if ketones present o 150 min/wk of moderate aerobic activity o Concern: hypoglycemia ▪ Do accuchecks before, during, & after ▪ If BSL < 100, eat 10-15 g carb and recheck in 15-30 min o Wait to exercise 1 hr post meal
  • Self-monitoring of blood glucose o Self-monitoring of Blood Glucose o Do comparison of results with lab every 6-12 months o 2-4 times/day o Need to keep a log o Puncture on side of finger o Urine : check ketones for type 1, during sickness & pregnancy o Type 1 diabetes ▪ Often test their blood glucose before meals. ▪ Checking blood glucose 2hrs after the first bite of food  determine if the bolus dose was adequate o During illness: check blood glucose levels at 4-hour intervals - Diet, exercise, and weight loss may be sufficient for Type 2
  • Decrease o Lipid levels o Calories & fat to have normal glucose, lipid, & B/P levels ▪ Even a 10% weight reduction can cause large improvements in glucose levels
  • Alcohol : Main danger is hypoglycemia
  • Insulin to carb ratio: 1 units: 6 gm carbs

▪ Repeat BS in 15 min, if still low/symptomatic repeat. If BS rising, give meal within hour o If patient not alert: give IM glucagon or 20-50 ml D50 IVP, recheck BS and monitor: follow with meal once alert ▪ Nausea is a common reaction after glucagon injection. ▪ To prevent aspiration  turn the patient on the side until he or she becomes alert o Follow the “Rule of 15” to treat hypoglycemia. ▪ 15g carbs ▪ Check after 15 min ▪ Still less than 70  15g more carbs Diabetes insipidus

  • Differences from diabetes mellitus and Management – F&E risks
  • Your body can't properly balance fluid levels - Characterized by large amounts of dilute urine and increased thirst. o Amount urine produced can be ~ 20 liters per day.
  • Complications may include dehydration or seizures.
  • Fluid imbalance makes you very thirsty even if you've had something to drink.
  • Can be caused by damage to hormone secreting organs, genetics, or medications Vascular disorders module (2 parts) Webex Notes
  • Aneurysms - how to prevent it o Surgery- what are potential complications and how to prevent them, what should we monitor? - PAD vs CVI o PAD = Arterial - worried about pulses and oxygenated blood getting to tissues. o CVI = Venous – worried about backup of fluid
  • DVT and PAD o Know differences between antiplatelets (aspirin, Clopidogrel) & anticoagulants (warfarin) o what should we teach pts, whats the risk, how do we manage it? Venous- worried about backup of fluid
  • Pulses, edema, dull aches or no pain, skin assess - Effects on system o hypercoagulability of blood, arterial fibrillation, immobility, HF, pregnancy, stroke, obesity
  • Diagnostic - lab tests, venous compression ultrasound, duplex ultrasound, CTV Arterial- worried about pulses and oxygenated blood getting to tissues.
  • Ischemia, pulses, skin, temp, color - Effects on system o Smoking, diabetes, elevated lipid levels and cholesterol, high BP
  • Diagnostic segmental bp, ABI, MRA, angiograft, chest x-ray, echocardiogram Hypertension Lewis Tables 32.2, 32.3, 32.4, 32.5, 32.6, 32.7, 32.